Corcept Therapeutics Incorporated Congressional Trading
According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 3 trades in Corcept Therapeutics Incorporated (NASDAQ: CORT) since 2017, across 1 member, worth an estimated $48.50K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 1 buy against 2 sells, a modestly sell-led skew, with Democratic members responsible for 0% of the trades and Republican members 100%. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Corcept Therapeutics Incorporated (CORT) stock overview and the complete trade table below.
Price & congressional trade timeline
Party breakdown
Corcept Therapeutics congressional trading activity
| Politician | Published | Traded | Filed After | Type | Size | Return | Owner | |
|---|---|---|---|---|---|---|---|---|
| No congressional trades in this period. | ||||||||
Corcept Therapeutics (CORT) congressional trading FAQ
Can members of Congress legally trade Corcept Therapeutics (CORT) stock?
Yes. Members of Congress are permitted to trade individual stocks, including Corcept Therapeutics (CORT), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; it does not imply any trade was improper.
Are congressional Corcept Therapeutics (CORT) trades public?
Yes. Every congressional trade in Corcept Therapeutics (CORT) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.
How many times has Congress traded Corcept Therapeutics (CORT)?
Members of Congress have disclosed 3 trades in Corcept Therapeutics (CORT) worth $48.50K across 1 members, according to public STOCK Act filings.
Do Democrats or Republicans trade Corcept Therapeutics (CORT) more?
Across disclosed Corcept Therapeutics (CORT) trades, 0% were by Democrats and 100% by Republicans, led by Republicans (100%).
Browse all stocks Congress tradesCongressional trading overviewCorcept Therapeutics (CORT) stock overview
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.